1760 — Panion & BF Biotech Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedSmall CapFalling Star

Annual income statement for Panion & BF Biotech, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	1,569	1,901	2,399	1,882	2,030
Cost of Revenue
Gross Profit	814	912	1,319	974	1,070
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	1,464	1,736	1,984	1,724	1,823
Operating Profit	105	165	415	157	206
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	89.4	183	333	169	217
Provision for Income Taxes
Net Income After Taxes	27.9	104	182	77.2	125
Minority Interest
Net Income Before Extraordinary Items
Net Income	27.9	104	182	77.2	125
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	27.9	104	182	77.2	125
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.355	1.32	2.08	0.899	1.45
Dividends per Share